$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
How long do the side effects of dacomitinib last? How to overcome side effects?
2025-10-19 11:44:20
Check Details
[Drug Side Effects] How to deal with rashes after taking erlotinib hydrochloride tablets?
2025-10-19 11:44:20
Check Details
Does the targeted drug erlotinib have side effects? Does Erlotinib have serious side effects?
2025-10-19 11:44:20
Check Details
Are there any side effects of long-term use of Tepotinib Hydrochloride Tablets?
2025-10-19 11:44:20
Check Details
Are there any adverse reactions to taking Tagriss AZD9291?
2025-10-19 11:44:20
Check Details
Latest erlotinib news, indications, usage and side effects of erlotinib
2025-10-19 11:44:20
Check Details
How long can patients with pancreatic cancer live after taking erlotinib hydrochloride tablets? Erlotinib Hydrochloride Tablets Side Effects
2025-10-19 11:44:20
Check Details
What cancer types can cabozantinib be taken for? Are there any serious side effects?
2025-10-19 11:44:20
Check Details
Does the targeted drug icotinib have serious side effects? How long does it take for Icotinib to have side effects?
2025-10-19 11:44:20
Check Details
[Lung Cancer Drug Competition] Which one has more side effects, osimertinib or icotinib?
2025-10-19 11:44:20
Check Details
What are the side effects of dacomitinib? How to avoid
2025-10-19 11:44:20
Check Details
What are the side effects of Icotinib Hydrochloride Tablets
2025-10-19 11:44:20
Check Details
1
2
...
4093
4094
4095
4096
4097
4098
4099
...
4151
4152
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Trodelvy® (Sacituzumab Govitecan-hziy): A Life-Changing ADC for Advanced Cancers
2
A Revolutionary Targeted Therapy for Hematological Malignancies
3
A New Option for Advanced Renal Cell Carcinoma Treatment
4
Trametinib (Mekinist): Precision MEK1/2 Inhibition Transforming Cancer Care Short Description:
5
Pirtobrutinib: A Novel BTK Inhibitor Offering Hope for Hematologic Cancer Patients Short Description:
6
Sacituzumab Govitecan: Trop-2 Targeted ADC Clinical Medication Guide
7
Fulvestrant (Faslodex) Breast Cancer Guide: Indications, Dosage and Safety Specifications
8
Adagrasib (Krazati): Full Guide to KRAS G12C Inhibitor for Cancer Treatment
9
Comprehensive Analysis of the Third-Generation EGFR-TKI
10
ATOMIC Study: Atezolizumab Plus Chemo Improves DFS in dMMR Stage III Colon Cancer
11
Oncology Immunotherapy vs Anti-Inflammatory Biologic: Dostarlimab vs Secukinumab - A Mechanism-Centered Comparison
12
Third-Generation TKI Redefining Treatment for ALK+ & ROS1+ NSCLC